questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Toxoïdes
Anatoxine staphylococcique
Anatoxine staphylococcique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections à Staphylococcus
Diagnostic microbiologique
Anticorps
Tests sérologiques
Symptômes
Infections à Staphylococcus
Staphylococcus
Identification des espèces
Anatoxines
Réponse immunitaire
Symptômes
5
Intoxication alimentaire
Symptômes
Infections cutanées
Furoncles
Variabilité des symptômes
Staphylococcus
Réactions allergiques
Anatoxines
Prévention
5
Prévention des infections
Hygiène
Infections nosocomiales
Contrôle des infections
Vaccination
Personnes à risque
Transmission des infections
Hygiène personnelle
Traitements
5
Antibiotiques
Infections à Staphylococcus
Toxoïdes
Prévention des infections
Réactions allergiques
Antihistaminiques
Soins des plaies
Infections cutanées
Antibiotiques
Infections à Staphylococcus
Complications
5
Effets secondaires
Réactions allergiques
Septicémie
Défaillance organique
Gestion des complications
Antibiotiques
Infections chroniques
Traitement prolongé
Facteurs de risque
5
Facteurs de risque
Système immunitaire
Diabète
Infections à Staphylococcus
Athlètes
Infections cutanées
Hygiène
Infections communautaires
Personnes âgées
Système immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Anatoxine staphylococcique : Questions médicales les plus fréquentes",
"headline": "Anatoxine staphylococcique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Anatoxine staphylococcique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Anatoxine staphylococcique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Toxoïdes",
"url": "https://questionsmedicales.fr/mesh/D014121",
"about": {
"@type": "MedicalCondition",
"name": "Toxoïdes",
"code": {
"@type": "MedicalCode",
"code": "D014121",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.691"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Anatoxine staphylococcique",
"alternateName": "Staphylococcal Toxoid",
"code": {
"@type": "MedicalCode",
"code": "D013208",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fiona P Havers",
"url": "https://questionsmedicales.fr/author/Fiona%20P%20Havers",
"affiliation": {
"@type": "Organization",
"name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: fhavers@cdc.gov."
}
},
{
"@type": "Person",
"name": "Susan Hariri",
"url": "https://questionsmedicales.fr/author/Susan%20Hariri",
"affiliation": {
"@type": "Organization",
"name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States."
}
},
{
"@type": "Person",
"name": "Nasamon Wanlapakorn",
"url": "https://questionsmedicales.fr/author/Nasamon%20Wanlapakorn",
"affiliation": {
"@type": "Organization",
"name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
}
},
{
"@type": "Person",
"name": "Donchida Srimuan",
"url": "https://questionsmedicales.fr/author/Donchida%20Srimuan",
"affiliation": {
"@type": "Organization",
"name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
}
},
{
"@type": "Person",
"name": "Thaksaporn Thatsanathorn",
"url": "https://questionsmedicales.fr/author/Thaksaporn%20Thatsanathorn",
"affiliation": {
"@type": "Organization",
"name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Folliculocentric tinea versicolor: a case report.",
"datePublished": "2024-09-17",
"url": "https://questionsmedicales.fr/article/39285486",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13256-024-04765-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tinea versicolor: an updated review.",
"datePublished": "2022-11-14",
"url": "https://questionsmedicales.fr/article/36452877",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7573/dic.2022-9-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of the efficacy and safety of Unani Formulations in Pityriasis Versicolor: A randomized controlled trial.",
"datePublished": "2022-08-06",
"url": "https://questionsmedicales.fr/article/35940465",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jep.2022.115603"
}
},
{
"@type": "ScholarlyArticle",
"name": "Concurrent genotyping and expression of NLRP3 inflammasome in pityriasis versicolor patient's skin lesions.",
"datePublished": "2024-08-02",
"url": "https://questionsmedicales.fr/article/39093484",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00403-024-03221-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differential lipase virulence in Malassezia furfur dimorphism isolated from pityriasis versicolor patients and healthy individuals.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36840378",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/myc.13580"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Toxoïdes",
"item": "https://questionsmedicales.fr/mesh/D014121"
},
{
"@type": "ListItem",
"position": 6,
"name": "Anatoxine staphylococcique",
"item": "https://questionsmedicales.fr/mesh/D013208"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Anatoxine staphylococcique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Anatoxine staphylococcique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Anatoxine staphylococcique",
"description": "Comment diagnostiquer une infection staphylococcique ?\nQuels tests sont utilisés pour détecter l'anatoxine ?\nQuels symptômes indiquent une infection staphylococcique ?\nComment différencier les types de staphylocoques ?\nQuel rôle joue l'anatoxine dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Tinea+Versicolor#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Anatoxine staphylococcique",
"description": "Quels sont les symptômes d'une intoxication par anatoxine ?\nComment se manifestent les infections cutanées staphylococciques ?\nQuels signes indiquent une infection systémique ?\nLes symptômes varient-ils selon le type de staphylocoque ?\nQuels symptômes sont associés à l'anatoxine staphylococcique ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Tinea+Versicolor#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Anatoxine staphylococcique",
"description": "Comment prévenir les infections staphylococciques ?\nL'anatoxine staphylococcique est-elle vaccinante ?\nQuelles mesures de prévention en milieu hospitalier ?\nLes personnes à risque doivent-elles se faire vacciner ?\nComment éviter la transmission en milieu communautaire ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Tinea+Versicolor#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Anatoxine staphylococcique",
"description": "Quel traitement est recommandé pour une infection staphylococcique ?\nL'anatoxine staphylococcique est-elle un traitement ?\nComment traiter une réaction à l'anatoxine ?\nQuels soins sont nécessaires pour les infections cutanées ?\nQuand utiliser des antibiotiques pour les infections staphylococciques ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Tinea+Versicolor#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Anatoxine staphylococcique",
"description": "Quelles complications peuvent survenir avec une infection staphylococcique ?\nL'anatoxine peut-elle provoquer des effets secondaires ?\nQuels sont les risques d'une septicémie staphylococcique ?\nComment gérer les complications d'une infection ?\nLes infections staphylococciques peuvent-elles être chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Tinea+Versicolor#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Anatoxine staphylococcique",
"description": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?\nLes personnes diabétiques sont-elles plus à risque ?\nLes athlètes sont-ils à risque d'infections cutanées ?\nComment l'hygiène influence-t-elle le risque d'infection ?\nLes personnes âgées sont-elles plus vulnérables ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Tinea+Versicolor#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection staphylococcique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter l'anatoxine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques peuvent être utilisés pour détecter des anticorps contre l'anatoxine."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection staphylococcique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent rougeurs, gonflements, douleurs et parfois fièvre."
}
},
{
"@type": "Question",
"name": "Comment différencier les types de staphylocoques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses génétiques aident à identifier les espèces."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'anatoxine dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anatoxine est utilisée pour évaluer la réponse immunitaire aux infections staphylococciques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication par anatoxine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des nausées, vomissements et diarrhées."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les infections cutanées staphylococciques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles se manifestent par des furoncles, des abcès et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection systémique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, frissons, et signes de septicémie peuvent indiquer une infection systémique."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de staphylocoque ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la souche et le site d'infection."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à l'anatoxine staphylococcique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des réactions allergiques et des douleurs au site d'injection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections staphylococciques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et désinfecter les blessures aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "L'anatoxine staphylococcique est-elle vaccinante ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour immuniser contre certaines infections staphylococciques."
}
},
{
"@type": "Question",
"name": "Quelles mesures de prévention en milieu hospitalier ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protocoles stricts d'hygiène et de désinfection sont essentiels en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles se faire vacciner ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes à risque d'infections staphylococciques devraient envisager la vaccination."
}
},
{
"@type": "Question",
"name": "Comment éviter la transmission en milieu communautaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le partage d'objets personnels et maintenir une bonne hygiène personnelle."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour une infection staphylococcique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont souvent prescrits, selon la sensibilité de la souche."
}
},
{
"@type": "Question",
"name": "L'anatoxine staphylococcique est-elle un traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, c'est un toxoïde utilisé pour la prévention, pas pour le traitement."
}
},
{
"@type": "Question",
"name": "Comment traiter une réaction à l'anatoxine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent nécessiter des antihistaminiques ou des corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires pour les infections cutanées ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un drainage des abcès et des soins locaux sont souvent nécessaires."
}
},
{
"@type": "Question",
"name": "Quand utiliser des antibiotiques pour les infections staphylococciques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont utilisés lorsque l'infection est confirmée et nécessite un traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une infection staphylococcique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections profondes, des septicémies et des chocs toxiques."
}
},
{
"@type": "Question",
"name": "L'anatoxine peut-elle provoquer des effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des douleurs au site d'injection et des réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une septicémie staphylococcique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La septicémie peut entraîner des défaillances organiques et un risque accru de mortalité."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une infection ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prise en charge rapide avec des antibiotiques et des soins intensifs est cruciale."
}
},
{
"@type": "Question",
"name": "Les infections staphylococciques peuvent-elles être chroniques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent devenir chroniques et nécessiter un traitement prolongé."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent un système immunitaire affaibli, des interventions chirurgicales et des blessures."
}
},
{
"@type": "Question",
"name": "Les personnes diabétiques sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète augmente le risque d'infections staphylococciques en raison de la circulation sanguine altérée."
}
},
{
"@type": "Question",
"name": "Les athlètes sont-ils à risque d'infections cutanées ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les athlètes peuvent être à risque en raison de blessures et de contacts fréquents."
}
},
{
"@type": "Question",
"name": "Comment l'hygiène influence-t-elle le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise hygiène augmente le risque d'infections staphylococciques, surtout dans les milieux communautaires."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: fhavers@cdc.gov.
Publications dans "Anatoxine staphylococcique" :
3 publications dans cette catégorie
Affiliations :
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Science, University of Tennessee, Knoxville, TN, United States.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Science, University of Tennessee, Knoxville, TN, United States.
East Tennessee AgResearch and Education Center-Little River Animal and Environmental Unit, University of Tennessee, Walland, TN, United States.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
NYU School of Medicine, Skirball Institute of Biomolecular Medicine and Departments of Medicine and Microbiology, New York, NY 10016.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, Beijing 100080, China.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 100050, China.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, San Jose 95134, USA.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China. Electronic address: xluo@ipe.ac.cn.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 100050, China. Electronic address: maxiao421@sina.cn.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, Beijing 100080, China.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, Beijing 100080, China.
Publications dans "Anatoxine staphylococcique" :
Tinea versicolor is a very common condition. We reported a specific follicular manifestation and proposed that this particular presentation might be related to the patient's history of previous kerato...
A 46-year-old Asian woman of Han ethnicity presented to the clinic with trunk lesions for over a year. On physical examination: multiple light brown patches of varying size centered on hair follicles ...
Follicular tinea versicolor is a rare type of tinea versicolor. It is still not clear what causes tinea versicolor to become folliculocentric. This case may suggest that patients with a history of ker...
Tinea versicolor is a common superficial fungal infection of the skin with various clinical manifestations. This review aims to familiarize physicians with the clinical features, diagnosis and managem...
A search was conducted in July 2022 in PubMed Clinical Queries using the key terms "tinea versicolor" OR "pityriasis versicolor". The search strategy included all clinical trials, observational studie...
Tinea versicolor is caused by...
Selection of antifungal agents depends on several factors, including efficacy, safety, local availability, ease of administration, likelihood of compliance and potential drug interactions of the antif...
Pityriasis Versicolor (PV) is a commonly encountered infection of the skin caused by Malassezia species. Despite effective conventional antifungal drugs, the prevention and treatment of PV remain a ch...
This study aimed to evaluate the efficacy and safety of Unani formulations IHA (oral) and HK (topical) in the treatment of PV....
A single centre, randomized, active-controlled, parallel-group and open-label clinical study was carried out in the outpatient departments of the National Research Institute of Unani Medicine for Skin...
This study observed statistically and clinically significant post-treatment reduction in itching (test group vs. active control group; 73.4% vs. 89.1%), hypopigmentation (63.2% vs. 57.1%), hyperpigmen...
This study concluded that the test drugs (IHA and HK) were safe and effective in the treatment of PV. The oral (IHA) and local (HK) Unani formulations were tolerated well by all the participants The e...
The goal of this study is to investigate the impact of the rs35829419 SNP on the serum level of NLRP3, and to assess the relationship between NLRP3 and its SNP and vulnerability to Pityriasis versicol...
Malassezia furfur is a member of the human skin microbiomes that can cause various skin diseases. Dimorphism plays a role as the yeast phase predominates during skin colonisation whereas mycelial form...
To describe different media suitable for culturing Malassezia from the yeast phase into mycelial forms, with a particular focus on nutritional supplements and pH conditions....
Clinical M. furfur isolates from patients with PV and healthy individuals were used to investigate Malassezia dimorphism as well as the activity and expression of lipase enzymes....
Our experimental media were significantly more likely to promote mycelial growth in strains from healthy individuals compared to those from patients with PV. Lipase activity was increased in the mycel...
Overall, this study validated effective growth conditions to study M. furfur virulence factors and demonstrated that lipase is associated with M. furfur dimorphism....
We describe a case series of seven children presenting with pityriasis versicolor on the face, localized to the area of coverage by the mask. The increased use of face masks after the opening up of sc...
Recurrent and disseminated pityriasis versicolor (RDPV) is a common clinical entity, characterized by its recurrent and disfiguring nature. Studies demonstrated host genetic variations in the immune r...
Tinea versicolor (TV) is a superficial fungal disease caused by Malassezia furfur, most commonly affecting adolescents and adults. TV is uncommon among newborns, particularly those aged under one year...
Malassezia is a lipid-dependent cutaneous symbiotic fungal genus associated with tinea versicolor. Here, we first present a rare case of a young tinea versicolor patient with oral manifestations prese...
Tinea incognito (TI), or incognita, are superficial fungal dermatophyte infections that are changed in shape, most frequently because of topical, systemic steroids use and other immunosuppressants. Th...